These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 20445741)

  • 1. Tumor angiogenesis: insights and innovations.
    Nussenbaum F; Herman IM
    J Oncol; 2010; 2010():132641. PubMed ID: 20445741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic and anti-tumor properties of proteasome inhibitors.
    Daniel KG; Kuhn DJ; Kazi A; Dou QP
    Curr Cancer Drug Targets; 2005 Nov; 5(7):529-41. PubMed ID: 16305349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects.
    Battegay EJ
    J Mol Med (Berl); 1995 Jul; 73(7):333-46. PubMed ID: 8520966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis: regulators and clinical applications.
    Liekens S; De Clercq E; Neyts J
    Biochem Pharmacol; 2001 Feb; 61(3):253-70. PubMed ID: 11172729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic drugs: from bench to clinical trials.
    Quesada AR; Muñoz-Chápuli R; Medina MA
    Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and cerebral neoplasia.
    Platt SR
    Vet Comp Oncol; 2005 Sep; 3(3):123-38. PubMed ID: 19754768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
    Shinkaruk S; Bayle M; Laïn G; Déléris G
    Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
    Parmar D; Apte M
    Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.
    Das A; McGuire PG
    Prog Retin Eye Res; 2003 Nov; 22(6):721-48. PubMed ID: 14575722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiogenesis and its regulation].
    Iwaguchi T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):1-9. PubMed ID: 7678486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back.
    Monnier Y; Zaric J; Rüegg C
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):31-8. PubMed ID: 15720233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type IV collagen-derived angiogenesis inhibitors.
    Mundel TM; Kalluri R
    Microvasc Res; 2007; 74(2-3):85-9. PubMed ID: 17602710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
    Takakura N
    Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
    Harper J; Moses MA
    EXS; 2006; (96):223-68. PubMed ID: 16383021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells: from bench to bedside.
    Kalka C; Di Santo S
    Future Cardiol; 2006 Jul; 2(4):455-66. PubMed ID: 19804181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.